These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 17638879)

  • 1. The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescence.
    Linardic CM; Naini S; Herndon JE; Kesserwan C; Qualman SJ; Counter CM
    Cancer Res; 2007 Jul; 67(14):6691-9. PubMed ID: 17638879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.
    Keller C; Arenkiel BR; Coffin CM; El-Bardeesy N; DePinho RA; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2614-26. PubMed ID: 15489287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma.
    Naini S; Etheridge KT; Adam SJ; Qualman SJ; Bentley RC; Counter CM; Linardic CM
    Cancer Res; 2008 Dec; 68(23):9583-8. PubMed ID: 19047133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
    Hu Q; Yuan Y; Wang C
    PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors.
    de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR
    Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.
    Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ
    Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.
    Anderson J; Ramsay A; Gould S; Pritchard-Jones K
    Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.
    Zhang Y; Wang C
    Oncogene; 2011 Aug; 30(32):3549-62. PubMed ID: 21423212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
    Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
    J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein.
    Xia SJ; Rajput P; Strzelecki DM; Barr FG
    Lab Invest; 2007 Apr; 87(4):318-25. PubMed ID: 17297479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE; Jeon IS; Shapiro DN
    Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR.
    Ebauer M; Wachtel M; Niggli FK; Schäfer BW
    Oncogene; 2007 Nov; 26(51):7267-81. PubMed ID: 17525748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX3-FKHR transformation increases 26 S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression.
    Zhang L; Wang C
    J Biol Chem; 2003 Jan; 278(1):27-36. PubMed ID: 12401804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG
    Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal and rearranged PAX3 expression in human rhabdomyosarcoma.
    Frascella E; Toffolatti L; Rosolen A
    Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
    Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ
    Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cooperative transforming effects of PAX3-FKHR and IGF-II on mouse myoblasts.
    Wang W; Slevin M; Kumar S; Kumar P
    Int J Oncol; 2005 Oct; 27(4):1087-96. PubMed ID: 16142327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.
    Tarnowski M; Grymula K; Reca R; Jankowski K; Maksym R; Tarnowska J; Przybylski G; Barr FG; Kucia M; Ratajczak MZ
    Mol Cancer Res; 2010 Jan; 8(1):1-14. PubMed ID: 20068066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.